Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

Clinical trial data shows RAD 101 detects Brain Metastases

by admin February 10, 2025
February 10, 2025
Clinical trial data shows RAD 101 detects Brain Metastases

Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases

Download the PDF here.

This post appeared first on investingnews.com

previous post
6 Biggest Crypto-Mining Stocks
next post
High-Grades up to 65g/t Au at Second Fortune Gold Mine

Related Posts

5 Biggest Pharmaceutical ETFs in 2025

May 7, 2025

Syntheia Announces First 1,000 Subscriptions

February 15, 2025

Drilling Underway at Lac Carheil

February 28, 2025

5 Canadian Potash Stocks

February 12, 2025

Forte Minerals to Present at the Swiss Mining...

March 15, 2025

Significant Uranium anomalies identified across the NT

June 17, 2025

Ulytau Project Exploration Licence Granted

March 19, 2025

Tech Stocks, Cryptocurrencies Pull Back as OpenAI Competitor...

January 28, 2025

Greenland Tanbreez Project Maiden Drill Results

January 25, 2025

Feedback of U.S. Department of Defense Award Funding

May 19, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved